アルツハイマー病におけるヒトマイクロアレイデータメタアナリシスを用いた遺伝子発現パターンの探索
Eleni Dermitzaki1,2,3, Vasileios L Zogopoulos1,2, Apostolos Malatras4
1Center of Systems Biology, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
Biology
|February 26, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
関連する概念動画
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
DNA Microarrays
21.5K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.5K


